A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.
Jpn J Clin Oncol
; 51(6): 956-965, 2021 May 28.
Article
in En
| MEDLINE
| ID: mdl-33829270
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Acrylamides
/
Receptor, IGF Type 1
/
Adenocarcinoma of Lung
/
Aniline Compounds
/
Lung Neoplasms
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Jpn J Clin Oncol
Year:
2021
Document type:
Article
Affiliation country: